| Attribute |
Value |
| 52 Week Change |
-0.21056908 |
| Address1 |
Building 5 |
| Address2 |
Croxley Park Hatters Lane |
| All Time High |
52.26 |
| All Time Low |
5.002001 |
| Ask |
29.27 |
| Ask Size |
900 |
| Average Analyst Rating |
2.4 - Buy |
| Average Daily Volume10 Day |
1,281,800 |
| Average Daily Volume3 Month |
1,510,274 |
| Average Volume |
1,510,274 |
| Average Volume10Days |
1,281,800 |
| Beta |
0.688 |
| Bid |
28.71 |
| Bid Size |
200 |
| Book Value |
2.4344 |
| City |
Watford |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United Kingdom |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
28.97 |
| Current Ratio |
2.139 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,786,665,600 |
| Day High |
29.025 |
| Day Low |
28.755 |
| Debt To Equity |
73.069 |
| Display Name |
Smith & Nephew |
| Dividend Date |
1,793,923,200 |
| Dividend Rate |
0.79 |
| Dividend Yield |
2.73 |
| Earnings Call Timestamp End |
1,785,873,600 |
| Earnings Call Timestamp Start |
1,785,873,600 |
| Earnings Growth |
0.057 |
| Earnings Quarterly Growth |
0.034 |
| Earnings Timestamp |
1,785,846,600 |
| Earnings Timestamp End |
1,785,846,600 |
| Earnings Timestamp Start |
1,785,846,600 |
| Ebitda |
1,382,000,000 |
| Ebitda Margins |
0.21937001 |
| Enterprise To Ebitda |
46.797 |
| Enterprise To Revenue |
10.266 |
| Enterprise Value |
64,673,628,160 |
| Eps Current Year |
2.22395 |
| Eps Forward |
2.42711 |
| Eps Trailing Twelve Months |
1.46 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,790,899,200 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
30.236 |
| Fifty Day Average Change |
-1.2660007 |
| Fifty Day Average Change Percent |
-0.041870642 |
| Fifty Two Week Change Percent |
-21.056908 |
| Fifty Two Week High |
38.79 |
| Fifty Two Week High Change |
-9.820002 |
| Fifty Two Week High Change Percent |
-0.25315806 |
| Fifty Two Week Low |
28.56 |
| Fifty Two Week Low Change |
0.40999985 |
| Fifty Two Week Low Change Percent |
0.014355737 |
| Fifty Two Week Range |
28.56 - 38.79 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
942,762,600,000 |
| Five Year Avg Dividend Yield |
2.59 |
| Float Shares |
2,104,764,816 |
| Forward Eps |
2.42711 |
| Forward P E |
11.936007 |
| Free Cashflow |
1,059,000,000 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
17,000 |
| Fullday Change |
-0.16 |
| Fullday Change Percent |
-0.549261 |
| Fullday Price |
28.72 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.68444 |
| Gross Profits |
4,312,000,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0001 |
| Held Percent Institutions |
0.114879996 |
| Implied Shares Outstanding |
418,506,356 |
| Industry |
Medical Devices |
| Industry Disp |
Medical Devices |
| Industry Key |
medical-devices |
| Ir Website |
http://global.smith-nephew.com/master/investor_centre_2738.htm |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,774,569,600 |
| Last Dividend Value |
0.482 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,413,331,200 |
| Last Split Factor |
2,499:1000 |
| Long Business Summary |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. |
| Long Name |
Smith & Nephew plc |
| Market |
us_market |
| Market Cap |
12,124,129,280 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_97461 |
| Most Recent Quarter |
1,782,518,400 |
| Net Income To Common |
635,000,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
12,204,984,440 |
| Number Of Analyst Opinions |
5 |
| Open |
28.89 |
| Operating Cashflow |
1,339,000,064 |
| Operating Margins |
0.14466 |
| Payout Ratio |
0.532 |
| Peg Ratio |
1.23 |
| Phone |
44 1923 477 100 |
| Post Market Change |
-0.25 |
| Post Market Change Percent |
-0.8629617 |
| Post Market Price |
28.72 |
| Post Market Time |
1,787,959,902 |
| Previous Close |
29.13 |
| Price Eps Current Year |
13.026372 |
| Price Hint |
2 |
| Price To Book |
11.900262 |
| Price To Sales Trailing12 Months |
1.924465 |
| Profit Margins |
0.10079 |
| Quick Ratio |
1.109 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.4 |
| Region |
US |
| Regular Market Change |
-0.16 |
| Regular Market Change Percent |
-0.549261 |
| Regular Market Day High |
29.025 |
| Regular Market Day Low |
28.755 |
| Regular Market Day Range |
28.755 - 29.025 |
| Regular Market Open |
28.89 |
| Regular Market Previous Close |
29.13 |
| Regular Market Price |
28.97 |
| Regular Market Time |
1,787,947,202 |
| Regular Market Volume |
1,488,333 |
| Return On Assets |
0.051599998 |
| Return On Equity |
0.11851 |
| Revenue Growth |
0.046 |
| Revenue Per Share |
2.9464 |
| Sand P52 Week Change |
0.20504117 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
418,506,356 |
| Shares Percent Shares Out |
0.0116 |
| Shares Short |
4,873,248 |
| Shares Short Previous Month Date |
1,784,073,600 |
| Shares Short Prior Month |
4,508,172 |
| Short Name |
Smith & Nephew SNATS, Inc. |
| Short Percent Of Float |
0.0117 |
| Short Ratio |
2.8 |
| Source Interval |
15 |
| Symbol |
SNN |
| Target High Price |
38.0 |
| Target Low Price |
30.0 |
| Target Mean Price |
33.664 |
| Target Median Price |
33.77 |
| Total Cash |
754,000,000 |
| Total Cash Per Share |
0.354 |
| Total Debt |
3,784,999,936 |
| Total Revenue |
6,300,000,256 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.397 |
| Trailing Annual Dividend Yield |
0.013628563 |
| Trailing Eps |
1.46 |
| Trailing P E |
19.842464 |
| Trailing Peg Ratio |
1.2339 |
| Triggerable |
1 |
| Two Hundred Day Average |
32.14175 |
| Two Hundred Day Average Change |
-3.171751 |
| Two Hundred Day Average Change Percent |
-0.098680094 |
| Type Disp |
Equity |
| Volume |
1,488,333 |
| Website |
https://www.smith-nephew.com |
| Zip |
WD18 8YE |